Editor's Note
This systematic review, meta-analysis, and trial sequential analysis by UK researchers find that the FDA-approved, anti-parasitic drug ivermectin could reduce COVID-19 related deaths and infections.
The data showed:
Ivermectin is likely to be an equitable, acceptable, and feasible global intervention against COVID-19, the authors concluded.
Robotic surgery has moved from cutting-edge to commonplace. The question…
Office-based surgery (OBS) is one of the fastest-growing care settings…
Stress and burnout are more than workforce concerns; they are…
Free Daily News